Leading-edge equipment engineered for rapid, accurate, and reliable medical testing.
The global healthcare industry is witnessing a paradigm shift from centralized laboratory testing to decentralized, patient-centric diagnostics. Point-of-Care Testing (POCT) has emerged as the cornerstone of this revolution, providing rapid results that allow for immediate clinical decision-making. As an industry leader, Ningbo Medvok Medical Co., Ltd. stands at the forefront of this transition, bridging the gap between high-tech biotechnology R&D and mass-scale production.
Current market data suggests the POCT market will exceed $70 billion by 2030, driven by an aging global population, the rising prevalence of chronic diseases like diabetes and cardiovascular conditions, and the urgent need for infectious disease monitoring. The demand for reliable China wholesale point-of-care devices is not just about cost—it's about the information gain provided by real-time data that saves lives in emergency rooms, remote clinics, and home care environments.
Countries Served
13485 Certified
DNA of Innovation
Global Support
China's diagnostic industry hubs, particularly in Ningbo and Shenzhen, offer unparalleled integration. From raw materials like antibodies and antigens to plastic housing and advanced microfluidic chips, the entire ecosystem is optimized for speed and cost-efficiency.
Companies like Bioantibody are not just factories; they are innovation hubs. With deep expertise in cardiovascular, inflammation, and infectious diseases, we offer tailored solutions from "raw materials to finished products," ensuring your unique market needs are met.
Quality is the bedrock of medical trust. By utilizing the ISO 13485 management system, Chinese manufacturers ensure that every rapid test strip and biochemical analyzer meets rigorous international standards, gaining the trust of healthcare providers in 60+ countries.
At Ningbo Medvok, our focus spans the entire spectrum of modern medicine. We provide high-tech biotechnology solutions covering:
Our mission, "Biotech For A Better Life", reflects our commitment to human ecology and health, ensuring society has access to clean, affordable, and reliable biotechnologies.
The next generation of POCT devices will integrate Artificial Intelligence to assist in result interpretation and cloud-based data sharing for remote patient monitoring.
From "Gentier Mini" portable PCR systems to handheld ultrasound devices, the trend is moving toward making hospital-grade diagnostics small enough for a pocket.
As per our sustainability policy, the industry is moving toward eco-friendly reagents and energy-efficient manufacturing, such as dry electrode technology.
Providing instant blood analysis and infectious disease screening without the need for a large-scale central lab.
Rapid diagnostic kits for cardiac markers and ultrasound systems for immediate internal assessment during the "Golden Hour".
Portable PCR and biochemical systems enable high-level medicine in regions with limited infrastructure, supported by silent-running power solutions.
Advanced tools for dental, surgical, and comprehensive health monitoring.
At Ningbo Medvok Medical Co., Ltd., we sincerely believe we could make our special contribution to human ecology and health. Our economic development is strictly compatible with proper conduct in relation to ethics, society, the workplace, the environment, and respect for human rights. We think of society as a group of individuals with equal rights and opportunities.
As an IVD solutions provider, we have worked and will keep working intensively to support research and foment knowledge and prevention of diseases. For us, a well-informed society is a healthier society.
Medvok Medical
